Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0253 Transporter Info
Gene Name	SLC2A11
Transporter Name	Glucose transporter type 11
Gene ID	66035
UniProt ID	Q9BYW1

Post-Translational Modification of This DT
Overview of SLC2A11 Modification Sites with Functional and Structural Information
Sequence	M R A L R R L I Q G R I L L L T I C A A G I G G T F Q F G Y N L S I I N A P T L H I Q E F T N E T W Q A R T G E P L P D H L V L L M W S L I V S L Y P L G G L F G A L L A G P L A I T L G R K K S L L V N N I F V V S A A I L F G F S R K A G S F E M I M L G R L L V G V N A G V S M N I Q P M Y L G E S A P K E L R G A V A M S S A I F T A L G I V M G Q V V G L R E L L G G P Q A W P L L L A S C L V P G A L Q L A S L P L L P E S P R Y L L I D C G D T E A C L A A L R R L R G S G D L A G E L E E L E E E R A A C Q G C R A R R P W E L F Q H R A L R R Q V T S L V V L G S A M E L C G N D S V Y A Y A S S V F R K A G V P E A K I Q Y A I I G T G S C E L L T A V V S C V V I E R V G R R V L L I G G Y S L M T C W G S I F T V A L C L Q S S F P W T L Y L A M A C I F A F I L S F G I G P A G V T G I L A T E L F D Q M A R P A A C M V C G A L M W I M L I L V G L G F P F I M E A L S H F L Y V P F L G V C V C G A I Y T G L F L P E T K G K T F Q E I S K E L H R L N F P R R A Q G P T W R S L E V I Q S T E L
PTM type	X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A11			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	47
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC2A11 Asparagine 47 has the potential to affect its expression or activity.
Phosphorylation
Serine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A11			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	236
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A11 Serine 236 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC2A11			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	487
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A11 Serine 487 has the potential to affect its expression or activity.
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A11			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	91
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A11 Threonine 91 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A11			[5]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	293
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A11 Tyrosine 293 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC2A11			[5]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	295
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A11 Tyrosine 295 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: GTR11_HUMAN)
2	Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol. 2013 Nov;14(11):1166-72.
3	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
4	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
5	Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics. 2015 Jan;15(2-3):508-519.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence